Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Real-world comparison of survival outcomes with cisplatin versus carboplatin in patients with limited-stage small-cell lung cancer

Cancer Treatment and Research Communications(2023)10.1016/j.ctarc.2023.100686Source: DataRank Database

Real-world comparison of survival outcomes with cisplatin versus carboplatin in patients with limited-stage small-cell lung cancer is a research paper published in Cancer Treatment and Research Communications (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.58)OA: goldTopics (24)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Kathleen Kerrigan ORCID,Jennifer A. Sinnott ORCID,Sonam Puri ORCID,Wallace Akerley ORCID,Benjamin Haaland ORCID

Live enrichment

PubMed:36736060 OpenAlex:https://openalex.org/W4317666055

National Institutes of Health

Grant: P30CA042014

FWCI

0.58

Citation Percentile

0.6%

Citation Trend

2024

2025

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.ctarc.2023.100686

publisherhttps://doi.org/10.1016/j.ctarc.2023.100686

publisherhttps://api.elsevier.com/content/article/PII:S2468294223000072?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2468294223000072?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36736060

Fields of Study

Lung Cancer Research StudiesNeuroendocrine Tumor Research AdvancesPneumonia and Respiratory Infections

MeSH Terms

AgedAntineoplastic Combined Chemotherapy ProtocolsCisplatinHumansLung NeoplasmsPlatinumCarboplatinTreatment OutcomeSmall Cell Lung Carcinoma

Keywords

CarboplatinMedicineCisplatinInternal medicineOncologyEtoposidePropensity score matchingHazard ratioLung cancerProportional hazards modelChemotherapyConfidence interval

Sustainable Development Goals

SDG 0: Good health and well-being